Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. Experimentation is vital.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. without any compliance process or technology in place.". The risks and penalties are real.

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

SEPTEMBER 21, 2015

Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. They just weren’t putting together a high-quality product. This way, any information her team needed from finance, sales, or any other department would arrive on time and in the specified format.

Management 8

Management Pharmaceuticals Learning-by-Doing Marketing 8

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

APRIL 5, 2012

This allowed the business to grow sales productivity by 7 percent and give back a budgeted $2 million for additional headcount — the productivity improvements allowed the sales organization to meet growth goals without adding people. GE also used the information to redeploy several sales territories into more lucrative markets.

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

MAY 15, 2013

It also focuses our attention on the forces that shape behavior in organizations, and so highlights an important question: are all those forces (including structure, processes, and incentives) "culture" or is culture simply the behavioral outputs? "In In large part, culture is a product of compensation." — Alec Haverstick.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

FEBRUARY 26, 2013

But when leaders take this conservative growth approach even when there is reasonable certainty of success and available financing, they undersize their sales forces and forfeit opportunity. Split a Territory as Soon as Its Sales Hit a Threshold Level. Do analysis that focuses on customers, not financial constraints.

Company 8

Company Short-term Long-term Cost 8

Harvard Business Review

FEBRUARY 4, 2013

For example, the rapidly evolving field of biomimicry examines nature's models and processes to help solve human problems. Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. Breakthrough requires an end to systemic inequities by opening up processes, information - and markets.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

OCTOBER 24, 2014

Here are some of the challenges that I’ve observed: Product management. Successful IoT plays require more than simply adding connectivity to a product and charging for service — something many companies don’t immediately understand. When product-based companies add services and connectivity, operational requirements increase.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

APRIL 23, 2012

For anyone involved in the sales process, a case before the U.S. Supreme Court is expected to rule on whether the work done by pharmaceutical salespeople really counts as "selling." pharmaceutical industry could face billions in retroactive overtime. The salesperson is still a vital link in this process. By June, the U.S.

Pharmaceuticals 13

Pharmaceuticals Banking Objective Incentives 13

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JANUARY 10, 2013

billion due to derelict mortgage and foreclosure processes. initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement.

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

NOVEMBER 20, 2015

Corporate procurement processes are opaque, secretive, and can be influenced by political pull as well as pure performance. In the clubby world of pharmaceutical purchasing executives, PACIV’s reputation for transparency spread, setting a higher bar that his competitors begrudgingly were now asked to jump over.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

JANUARY 26, 2016

and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields. The analyst was involved in product launches. Perhaps the analysts involved with product launches are thus given more of a mandate than analysts involved in other kinds of activities.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

JUNE 20, 2017

With the confirmation of Robert Lighthizer as United States trade representative, the long-delayed start of the formal process to begin renegotiation of NAFTA with Canada and Mexico can move forward. Congress of its intent to begin the process. So, if a company manufactures products in Mexico to export to Canada and the U.S.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

Supply Chain 9

Supply Chain Productivity Products Company 9

Harvard Business Review

AUGUST 23, 2016

Both Republicans and Democrats say the most effective board committee is audit/finance. ” Directors of both political views rate their boards similarly on processes, dynamics, and effectiveness as a whole, but differ on the question of compensation. chemicals, metals & mining, paper & forest products).

Politics 8

Politics Committee Telecommunications Diversity 8